NCT06332859 Effectiveness of a Resilience-Based Rehabilitation Program for Patients With Coronary Heart Disease
| NCT ID | NCT06332859 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Pensionsversicherungsanstalt |
| Condition | Takotsubo Cardiomyopathy |
| Study Type | INTERVENTIONAL |
| Enrollment | 130 participants |
| Start Date | 2024-04-15 |
| Primary Completion | 2026-10-14 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 130 participants in total. It began in 2024-04-15 with a primary completion date of 2026-10-14.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To handle daily life challenges, one needs to be psychologically resilient. It plays a crucial role in disease development, prognosis, as well as social, occupational, and community participation. Cardiovascular diseases cause physical and psychological stress, which can be linked to individual resilience and the development of such diseases. Stress can trigger TakoTsubo cardiomyopathy and acute coronary events. Individuals who have experienced TakoTsubo cardiomyopathy or an acute coronary event often feel stressed due to emotional or physical triggers. These triggers may include job loss or illness. In medical rehabilitation, therapists consider the individual circumstances of their patients when planning therapy. It may be important to add a special focus on psychological care, including building resilience, which could greatly benefit these individuals. Therefore, the study aims to investigate whether resilience training, as part of an inpatient multidisciplinary rehabilitation program, affects the individual resilience of rehabilitants with TakoTsubo cardiomyopathy or those who have experienced an acute coronary event.
Eligibility Criteria
Inclusion Criteria: * patients experienced TakoTsubo cardiomyopathy (I42.88, I42.9) or patients after an acute coronary event (I21.9) (max. 6 month post event) * older than 18 years * signed consent form Exclusion Criteria: * Acute intercurrent illness (longer than 3 days) * No sufficient knowledge of German to enable participation in the resilience training (assessment by recruiting person)
Contact & Investigator
Doreen Stöhr, Mag.
STUDY CHAIR
Austrian Pension Insurance Institution
Frequently Asked Questions
Who can join the NCT06332859 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Takotsubo Cardiomyopathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06332859 currently recruiting?
Yes, NCT06332859 is actively recruiting participants. Contact the research team at marina.kuzdas-sallaberger@pv.at for enrollment information.
Where is the NCT06332859 trial being conducted?
This trial is being conducted at Bad Tatzmannsdorf, Austria.
Who is sponsoring the NCT06332859 clinical trial?
NCT06332859 is sponsored by Pensionsversicherungsanstalt. The principal investigator is Doreen Stöhr, Mag. at Austrian Pension Insurance Institution. The trial plans to enroll 130 participants.